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With  the  development  of methods  to  isolate  human  megakaryocytes,  it  is  now 
possible  to  study  marrow  megakaryocytes  for  various  biological  properties  (1-3). 
Megakaryocytes are  unique  cells  in  that  they undergo  nuclear endoreplication  and 
cytoplasmic  demarcation,  giving  rise  to  blood  platelets  (4).  Platelets  are  essential 
components in hemostasis and participate  in the pathophysiology of thrombosis and 
atherosclerosis (5-7). Platelets are nonnucleated cells and carry only a vestigial protein 
synthetic apparatus  (8,  9).  Previous studies  have demonstrated  that  the  majority of 
human  megakaryocytes  contain  fibrinogen,  platelet  myosin,  plasma  factor  VIII 
antigen  (factor  VIII:AGN),  1 and  platelet  membrane  glycoproteins  (1,  2).  Growth- 
promoting  activity,  or  megakaryocyte-derived  growth  factor(s),  similar  to  platelet- 
derived growth factor(s)  has been demonstrated  in human megakaryocytes (3). 
Studies on megakaryocytopoiesis in the murine system have been greatly facilitated 
by  the  use  of a  selective  cytochemical  marker,  acetylcholinesterase  activity  (10).  A 
population of early, differentiated,  immature  megakaryocytes that  contained acetyl- 
cholinesterase  activity was described  in  mouse  and  rat  marrow  (10-12).  Analysis of 
early  megakaryocytes in  these  systems  has  brought  new  insight  into  the  regulatory 
mechanisms of platelet  production  (13-14).  Similar  markers,  however,  have not yet 
been established for human megakaryocytes. Recently, Mazur et al. (15) have reported 
the expression of platelet glycoproteins in colony megakaryocytes grown in vitro using 
the plasma clot technique. 
In this communication, analysis of several platelet  proteins by immunofluorescence 
revealed that platelet  glycoproteins Ib, IIb, and IIIa, as well as factor VIII:AGN, and 
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platelet factor 4  are  present  in  virtually all of marrow  megakaryocytes and  can  be 
considered to be distinct protein markers of this cell line. These same proteins were 
detected in a  small proportion of lymphoid-like mononuclear marrow cells regarded 
as  immature,  differentiated  megakaryocytes or  early megakaryocytes.  Early  mega- 
karyocytes bear Fc receptors for IgG but  lack expression of Ia antigens. Characteri- 
zation of megakaryocytic cells using platelet protein  markers  may  be  helpful  for a 
better understanding of altered megakaryocyte maturation in various disorders. 
Materials  and  Methods 
Prepara.tion of Human  Bone Marrow Cell  Suspensions.  Suspensions  of human  marrow  cells 
enriched for megakaryocytes were prepared using density centrifugation gradients as described 
previously (1,  2).  Marrow  tissue was  obtained  from  rib  fragments routinely removed from 
patients undergoing thoracotomy. Written consent was procured from all participating patients 
before surgery in compliance with regulations established by the National Institutes of Health, 
Bethesda, Md. Experimental protocols were approved by The Committee on Human Rights of 
New  York Hospital-Cornell Medical Center and  Memorial Sloan-Kettering Cancer Center, 
New York. To obtain single-cell suspension of marrow cells, rib specimens were debrided, cut 
into 2-4-cm sections, and the marrow tissue promptly harvested with medium as described in 
more detail elsewhere (1, 2). The medium used throughout the procedures consisted of calcium- 
and magnesium-free Hanks' balanced salt solution (Grand Island Biological Co., Grand Island, 
N. Y.) containing 10  -3 M  adenosine, 2 X  10  -n M  theophylline, 1.25 ×  10  -s M  sodium citrate, 
2.52 X  10  -5 M  Hepes buffer, 4.1 x  10  -s M sodium bicarbonate, and 115 U/ml of DNAse I (all 
from Sigma Chemical Co., St. Louis, Mo.) at a  final pH of 7.0  +  0.05  and 295  +  5 mosM 
(HBSS'/CAT). 
Initial  enrichment  of  the  megakaryocytes  and  the  putative  early  megakaryocytes was 
achieved by a slight modification of the density-gradient centrifugation technique previously 
described (1, 2). As reported, gradients were generated with solutions of colloidal silica particles 
coated with polyvinyl pyrrolidone (Percoll; Pharmacia Fine Chemicals, Div. of Pharmacia, 
Inc.,  Piscataway,  N. J.),  in  HBSS-/CAT  at  995  mosM,  pH  7.0.  The  modification of the 
technique consisted of (a) use of HBSS'/CAT (1.007  g/cm  a)  instead of 1.040 g/cm  a Percoll- 
medium and  (b) centrifugation of gradients at  725  g  for 20  min  at  20°C.  Density-gradient 
centrifugation was  performed  as  follows:  (aa) 7-8  ×  10  v marrow  cells resuspended  in  3  ml 
HBSS-/CAT containing 1.050 g Percoll/cm  were placed in 17- ×  10-mm polypropylene tubes; 
(b)  cells were  then  underlayered with  3  ml  HBSS-/CAT  medium  containing  1.085  g/cm  3 
Percoll and (c) overlayered with 3 ml of medium HBSS'/CAT. After centrifugation, the cells 
were harvested into three fractions. Fraction I  (d <  1.050 g/cm  a) comprised all the cells from 
the top gradient layer and the upper interface; fraction II (d ~  1.050 g/cm  3) consisted of the 
cells from the intermediate gradient layer; and fraction III (d >  1.050 g/cm  a) was made up of 
cells from the bottom gradient layer and the pellet. After harvesting each fraction, the cells 
were counted and examined for various protein antigens. Over 86%  of megakaryocytes and 
small lymphoid-like mononuclear cells were found in density fraction I. 
Preparation of Blood Leukocytes and Washed Platelets.  Blood samples were obtained from normal, 
healthy volunteers and a  patient with Glanzmann's thrombasthenia.  Blood was collected in 
0.32%  sodium citrate in polypropylene tubes. Leukocytes were prepared by resuspending the 
blood in 3% Dextran T500 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) HBSS-/CAT 
and allowing it to sediment at 20°C for 25 min. The leukocyte-enriched supernate, depleted of 
most erythrocytes, was washed twice in HBSS-/CAT by centrifugation at 225 g for 15 rain at 
20°C. Washed platelets were prepared by eentrifugation of whole citrate blood at 225 g for 10 
min at 20°C. The platelet-rich plasma supernate was then centrifuged at 1,600 g for 20 min at 
20°C and subsequently washed three times in a  0.12 M  sodium chloride solution containing 
0.0129 M  sodium citrate and 25 mM glucose at pH 6.8 (16).  Platelet counts were performed 
with a Coulter counter (model ZBI; Coulter Electronics Inc., Hialeah, Fla.). 
lmmunofluorescence Assay.  Monospecific rabbit  antisera against  purified factor VIII:AGN, 
fibronectin, and isolated platelet glycoproteins Ib, IIb, and IIIa were prepared and tested for 
specificity as described (17-21). Anti-human platelet factor 4 goat serum was a  generous gift 90  PLATELET  PROTEIN MARKERS  IN  MEGAKARYOCYTE DIFFERENTIATION 
from  Dr.  Karen Kaplan of Columbia University, New York  (21). Polyspecific  anti-platelet 
membrane serum was generated and tested as described (22). After isolation of the IgG fraction 
from each  antiserum by DEAE-cellulose chromatography, each  antibody was  treated  with 
pepsin (Worthington Biochemical Corp., Freehold, N. J.)  to produce F(ab')2 fragments (23). 
F(ab')2 fragments were separated from trace amounts of uncleaved IgG and pFc fragments by 
Sephacryl S-200 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) gel filtration. The F(ab')2 
fragments were  shown to be free  of uncleaved IgG and pFc fragments by sodium dodecyl 
suifate-polyacrylamide gel  electrophoresis and by immunodiffusion analysis with goat  anti- 
rabbit Fc fragment-specific antiserum. Alternatively, intact IgG antibody preparations were 
treated with soluble Staphylococcus aureus protein A (Pharmacia Fine Chemicals, Div. of Phar- 
macia, Inc.) to functionally  block the Fc region of the IgG molecule (24). Effective blockage of 
the Fc region, without protein precipitation, was obtained by incubating protein A with IgG 
solutions at a 7:1 wt:wt ratio, first at 37°C for 2 h and then at 4°C overnight. In most instances, 
direct immunofluorescence  was performed using either the IgG F(ab')2 or the protein A-coupled 
IgG antibody preparation conjugated to fluorescein isothiocyanate (FITC) or tetramethylrho- 
damine isothiocyanate (TRITC) (both from BBL Microbiology Systems,  Becton, Dickinson & 
Co., Cockeysville,  Md.) as described in more detail elsewhere  (23). After conjugation to FITC 
or TRITC, the IgG or IgG F(ab')2 antibody peparations were rechromatographed in DEAE- 
cellulose, and three fractions of the labeled gamma globulin were eluted sequentially with 0.01, 
0.05,  and 0.1  M  sodium phosphate buffer, pH 7.0. In general, the 0.05  M  sodium phosphate 
antibody preparation with a dye/protein molar ratio of 1 _  0.3 was found to have the highest 
specific  activity and  the  least  background staining. To  study the  antiserum specificity by 
immunofluorescence,  serial absorption of each antibody was performed with increasing  amounts 
of the specific  and nonrelated antigens such as bovine serum albumin (BSA) at 37°C for 30 
min and at 4°C for  12 h. Variations in the fluorescence staining of either megakaryocytes or 
platelets with eventual extinction with the specific  antigen were  the criteria for  specificity. 
Specificity of the  fibronectin antiserum was  further  tested  using cultured human marrow 
fibroblasts (25). Anti-platelet glycoproteins IIb and IIIa (1 mg/ml) were tested after incubation 
at 37°C for 30 min and at 4°C for 12 h with 2 ×  109 platelet/ml serum from either a normal 
donor or a patient with Glanzmann's  thrombasthenia. 
For fluorescence staining of membrane-restricted components, isolated marrow or blood cells 
(1-20 ×  106) or platelets (1-2 ×  108) were incubated with 0.03-0.07 ml of the fluoresceinated 
antibody in the presence of HBSS=/CAT containing  0.02% sodium azide and 1% BSA (HBSSffi/ 
CAT-NaNz-BSA) at 20°C for 30 min. Cells were then washed twice in HBSS=/CAT-NaN3- 
BSA. Fluorescence staining was also carried out by incubating  smears of cells with the different 
antibody preparations after fixing cells in pure methanol for 10 min followed  by three washes 
in phosphate-buffered saline (PBS). Cells were examined with a Leitz Ortholux II microscope 
(E. Leitz, Inc., Rockleigh, N. J.) equipped with Ploem illuminator and phase-contrast optics. 
Cells were  double-assayed for  two  proteins by staining cell  preparations simultaneously or 
sequentially with a TRITC-conjugated reagent and/or an FITC-conjugated specific  reagent. 
Double staining of cell preparations was performed using both cell suspensions and fixed cell 
smears. Combinations  of one or two markers on individual cells were separately enumerated by 
sequential examination of each microscopic field  with blue-light fluorescence (FITC), green- 
light fluorescence (TRITC), and visible-light phase-contrast optics. 
Detection of FC Receptors (FcR) and Ia Antigens.  Studies of membrane receptors for  the Fc 
portion of IgG and Ia antigens were performed by direct immunofluorescence as previously 
described (1-2). To detect FcR, 0.05~ 5.00  ×  105 megakaryocytes or 5-6 ×  106 marrow cells 
were incubated for  30 min at  20°C with a  soluble immune complex, prepared at  antibody 
excess with 25 p,l of rabbit IgG anti-ovalbumin conjugated to FITC and 25 p,1 of ovalbumin 
(26). Ia antigens were detected with a rabbit F(ab')2 anti-Ia-serum  conjugated to FITC prepared 
and tested as described elsewhere (27). The anti-Ia reagent was a donation of Dr. R. Winchester, 
The Rockefeller University, New York. After staining for FcR or Ia antigens, cells were smeared, 
fixed, and stained with antiplatelet glycoprotein IIb or Illa serum conjugated to TRITC. Cells 
were examined under fluorescence microscopy as mentioned above. E.  RABELLINO,  R.  LEVENE,  L.  LEUNG,  AND  R.  NACHMAN  91 
Results 
Expression  of Platelet  Proteins in  Marrow  Megakaryocytes.  Human  megakaryoeytes 
isolated from normal bone marrow tissue were studied for the presence of various 
platelet  proteins  using the  immunofluorescence technique  (Table  I).  Three  of the 
major platelet  glycoproteins (Ib, IIb, and IIIa), factor VIII:AGN, fibronectin, and 
platelet factor 4 were detected in virtually all isolated megakaryocytes. Analysis of the 
different  platelet  proteins  in  megakaryocyte-enriched marrow  preparations  were 
carried out either by staining fixed smears of cells or by incubating suspensions of 
viable  cells  with  the  different  monospecific  antisera.  Megakaryocyte components 
detected  using  the  fixed  cell  smears  were  located  primarily  intracellularly, while 
megakaryocyte components stained with cells suspended in the antisera were associ- 
ated with the cell membrane. The pattern of fluorescence staining for the different 
antigens was as previously described (1, 2, 28). Intracellular staining was characterized 
typically by intense homogeneous staining in all areas of the cells except the nucleus 
(Fig.  1 b). The membralae staining pattern consisted of uniformly distributed flecks 
throughout  the  cell  (Fig.  1 a).  The  megakaryocytic morphology of the  fluorescent 
stained cells was confirmed by concomitant examination of the cells under phase- 
contrast microscopy (Fig.  1 c). 
The monospecificity of each antiserum employed was demonstrated by immuno- 
diffusion, immunoprecipitation, and immunofluorescence. In the fluorescence studies, 
each antiserum was tested for its ability to stain megakaryocytes after absorption with 
the specific or a nonrelated antigen. Results of a typical immunofluorescence specific- 
ity experiment are depicted in Fig. 2. Highly purified plasma factor VIII:AGN, but 
not BSA, inhibited the detection of megakaryocyte factor VIII:AGN. Similar results 
were  observed  in  specificity experiments  conducted  for  anti-fibronectin  and  anti- 
platelet factor 4  antisera. Antisera against platelet  glycoproteins IIb and IIIa were 
found to be devoid of antibody activity after absorption of each antisera with normal 
platelets. On the contrary, platelets from a patient with Glanzmann's thrombasthenia 
proven  to be deficient in membrane glycoproteins IIb and IIIa failed to block the 
activity of both antisera (29, 30). Furthermore, the specificity of the reagents used was 
determined by analyzing the types of cells stained. With the exception of a  small 
population of low density marrow mononuclear cells (vide infra), megakaryocytes and 
platelets were the only two types of marrow and blood cells that stained with anti- 
platelet glycoproteins Ib, IIb, and IIIa, anti-factor VIII:AGN, and platelet factor 4 
TABLE  I 
Detection of Platelet Protein in Human Megakaryocytes by Immunofluorescence 
Antisera 
Percent of megakaryocytes stained 
After cell  fixation  In cell suspension 
(intracellular)  (membrane) 
Platelet glycoprotein Ib  96 ~  1"  95 ±  2 
Platelet glycoprotein IIb  99 zl:  1  98 •  1 
Platelet  glycoprotein IIIa  98 ±  2  98 ±  1 
Factor VIII:AGN  95 +  3  94 +  4 
Fibroneetin  93 --. 4  95 +  3 
Platelet  factor 4  85 -  2  0 
* Mean value and  1 SD of at least  12 experiments. FIc.  1.  lmmunofluorescent'staining  of isolated human marrow megakaryocytes. Factor VIII:AGN 
in megakaryocytes: (a)  membrane-associated factor VIII:AGN detected with a TRITC-conjugated 
antiserum; (b) factor VIII:AGN staining of the same megakaryocyte with a FITC-labeled antiserum 
after  fixation  of cells  with  methanol;  (c)  same  megakaryocyte  examined  under  phase-contrast 
microscopy. Platelet glycoprotein llIa in megakaryocytes: (d) membrane-associated platelet  glyco- 
protein IIIa detected with a TRITC-conjugated antiserum; (e) platelet glycoprotein IIIa staining of 
the same megakaryocyte with an FITC-labeled antiserum after fixation of cells with methanol; and 
(f) same megakaryocyte examined under phase-contrast microscopy. ×  1,200. 
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FIG.  2,  Effect  of  purified  factor  VIII:AGN  (0)  or  BSA  ((3) on  the  fluorescent  staining  of 
megakaryocytes with anti-factor VIII:AGN serum at 62/~g/ml. 
antisera.  This  firmly  established  the  selectivity  of these  reagents  for  cells  of the 
megakaryocytic lineage. 
To investigate the topographic distribution of the various antigens within isolated 
megakaryocytes, cell preparations were subjected to double assay for both membrane 
and  intracellular  fluorescence staining.  Cells  first  stained  for membrane-associated 
factor  VIII:AGN  with  TRITC-labeled  antiserum  were  subsequently  stained  for 
intracellular factor VIII:AGN with a  FITC-conjugated antiserum. As shown in Figs. 
1 a, b, and c, factor VIII:AGN was demonstrated on the cell membrane as well as in 
the  intracellular  compartment of megakaryocytes. Using the same staining system, 
platelet  glycoproteins Ib, lib, and IIIa, as well as fibronectin, were detected  on the 
membrane and in the intracellular compartment of all isolated megakaryocytes (Fig. 
1 d, e, and f). Platelet factor 4, on the other hand, was only found in the cytoplasm of 
most marrow megakaryocytes (Table I). 
In another series of experiments, the relationship between platelet glycoproteins lib 
and Ilia in  megakaryocytes was studied  by immunofluorescence.  Platelet  glycopro- 
teins lib and IIIa are known to be closely related functionally and to form a molecular 
complex in the platelet membrane (31,  32). The expression of platelet glycoproteins 
lib and IIIa in megakaryocytes as independent molecular entities was investigated by 
the capability of one of the monospeciflc antisera to affect the detection of the other 
glycoprotein. Detection of platelet glycoprotein lib or Ilia in smeared, methanol fixed 
megakaryocytes was not affected by simultaneous or alternate incubation of fixed cells 
with the two antisera (Fig. 3 a  and b). 
Identification of  Early Human Marrow Megakaryocytes or Megakaryocyte Precursors.  Studies 
were performed to determine whether the platelet marker proteins were also expressed 
within  marrow cells that  might  represent  megakaryocyte precursors or early mega- 
karyocytes  (10-14).  Analysis  of marrow  cell  preparations  by  immunofluorescence 
revealed that a minor proportion of small mononuclear marrow cells were stained for 
platetet glycoproteins Ib, IIb, IIIa, factor VIII:AGN, and platelet factor 4  (Table II). FI~.  3.  Immunofluorescence staining of human megakaryocytic cells.  Methanol-fixed low density 
marrow cells (< 1.050  g Percoll/cm 3) simultaneously stained with (a) FITC-conjugated  anti-platelet 
glycoprotein IIb serum and (b) TRITC-labeled  anti-platelet glycoprotein Illa serum;  (c) same field 
under phase-contrast  microscopy.  Arrow indicates small cell positively stained.  Small,  low density 
marrow cell double-assayed  for (d) membrane platelet glycoprotein Ilia (TRITC)  and  (e) intracel- 
lular platelet  glycoprotein  Illa  (FITC);  (f)  phase-contrast  microscopy.  Small,  low density marrow 
cell double-assayed  for (g)  membrane factor VIII:AGN  (TRITC)  and (h) platelet glycoprotein  Itb 
(FITC);  (i) phase-contrast microscopy  (a-f, ×  970; g-i, ×  1,200). E.  RABELLINO, R.  LEVENE,  L.  LEUNG, AND R.  NACHMAN  95 
TABLE II 
Identification of Small Mononuclear Marrow Cells Bearing Various Platelet Proteins by Immunofluorescence 
Stained mononuclear cells/104 marrow cells 
Antisera  After density centrifugation  in 
Percoll  Unseparated 
<1.050 g/cm  3  >1.050 g/cm  3 
Platelet glycoprotein Ib  2.9 +  1"  32 zl: 2  0 
Platelet glycoprotein lib  2.1 "t" 1.6  20 "4- 1  0 
Platelet glycoprotein IIIa  1.4 zlz 0.8  30:1:17  0 
Platelet polyspecific anti-membrane  2.0:1:0.1  46 + 3  0 
Factor VIII:AGN  2.8 + 0.2  39 zl: 2  0 
Platelet factor 4  1.5 :lz 0.6  36 :t: 4  0 
* Mean values and 1 SD of five experiments. Incidence of stained cells was established by counting at least 
4 x  104 cells in each preparation. 
Small cells specifically stained for these proteins represented between  1.4 and 2.9/104 
unseparated  marrow  cells.  The  same  incidence  was  observed  with  a  polyspecific 
antiplatelet  membrane  serum.  Most  of these  cells  had  low  cell  density  and  were 
harvested from  the low density fraction of the Pereoll density gradient representing 
-20-46/104  mononuclear  cells. Under  phase-contrast  microscopy, these cells had  a 
lymphoid-like appearance with a  round nucleus, an agranular cytoplasm, and a  high 
nuclear cytoplasmic ratio (Fig. 3 c, f, and i). The cell diameter was estimated at ~9- 
12 #m as compared with erythrocytes of the same cell preparation (6-8 #m). 
Studies of the topographic distribution of different platelet protein markers disclosed 
that  the four antigens investigated were  detected in the same cell compartments  as 
those described for mature  megakaryocytes. Platelet glycoproteins Ib, IIb, and IIIa, 
as well as factor VIII:AGN, were detected both on the membrane and intracellularly. 
On the other hand, platelet factor 4 was found only in the intracellular compartment. 
Small marrow cells stained for membrane and intracellular platelet glycoprotein IIIa 
are  shown  in  Fig.  3 d,  e,  and  f.  Moreover,  small low  density marrow  cells bearing 
factor VIII:AGN were found to contain platelet glycoprotein IIIa (Fig. 3 g, h, and i). 
Double-assay  experiments  performed  with  all  possible  combinations  of  antisera 
showed  that  approximately  two-thirds  of the  small  marrow  cells  bearing  platelet 
proteins bore at least two of the antigens tested. Quantitative assessment of individual 
small marrow cells containing only one or more protein markers was not  attempted 
because of the extremely low incidence of these cells. 
FoR and  Ia antigen  have been described as differentiation markers in cells of the 
megakaryocytic  series.  Using  the  combined-fluorescence  assay  for  membrane  and 
intracellular staining, it was found that FcR were detected in all precursors or early 
megakaryocytes containing platelet glycoproteins IIb and  IIIa. On  the contrary, Ia 
antigen was not  detected on any of early megakaryocytes bearing platelet glycopro- 
teins IIb and IIIa. 
In an  attempt  to determine whether  small marrow  cells bearing platelet proteins 
formed part of an  early megakaryocytic differentiation compartment,  the incidence 
of these cells was correlated with that of mature megakaryocytes and the number of 
blood platelets (Table III). The incidence of precursor or early megakaryocytes was 
estimated  by  the  number  of  small  mononuclear  cells  expressing  either  platelet 96  PLATELET PROTEIN MARKERS IN MEGAKARYOCYTE DIFFERENTIATION 
TAaLE III 
Correlative Analysis of Small, Low Density Marrow Cells Bearing Platelet Proteins with Megaka~yocytes 
and Platelets 
Number of cells bearing platelet 
protein/10  4 marrow cells*  Small cells: 
Blood platelets 
Marrow cells  megakaryocytes  (X  10n/liter) 
Small m0nonu-  Megakaryo-  ratio 
clear cells  cytes 
Unseparated  2.24 :t: 0.6~  4.4 +  0.3  0.51  307 +  89 
After density centrifugation  33.4 +  9.8  73.0 +  46  0.46 
(< 1.050  g Percoll/cm  ~) 
* Estimated by the number of cells bearing platelet glycoprotein IIb, IIIa, or factor VIII:AGN. 
:~ Mean values and  1 SD of at least eight experiments. 
glycoproteins  lib,  Ilia,  or  factor VIII:AGN.  In  normal,  unseparated  marrow  cell 
suspensions, the ratio of small cells:mature megakaryocytes bearing platelet markers 
was  -0.5.  After density-gradient centrifugation, the  ratio was  -0.46.  This similal 
ratio together with high recovery yield of the two types of cells indicated that analysis 
of megakaryocytic cells in  Percoll low-density fractions probably reflects the mega- 
karyocytic population of intact marrow tissue. 
Discussion 
Our studies demonstrate that human marrow megakaryocytes contain a number of 
platelet proteins that play key roles in normal platelet physiology. Platelet glycopro- 
teins Ib, IIb, and IIIa, as well as factor VIII:AGN, platelet factor 4, and fibronectin 
were detected by immunofluorescence in the vast majority of morphologically recog- 
nizable megakaryocytes. In addition, a  small proportion of lymphoid-like mononu- 
clear marrow cells was  found to express these platelet proteins. This population of 
small  mononuclear cells  was  regarded  as  early  megakaryocytes or  megakaryocyte 
precursors that formed part of an early megakaryocytic differentiation compartment. 
This population of early megakaryocytes may be analogous to the small acetylcholin- 
esterase-positive cells that have been described in the mouse and rat systems (10-14). 
Platelet glycoproteins Ib, IIb, and  IIIa, as well as platelet factor 4 and  factor VIII: 
AGN,  were  defned  as  distinct  markers  for  marrow  megakaryocytes and  may  be 
helpful for identifying megakaryocytic cells as well as for monitoring sequential events 
of megakaryocyte differentiation. 
These studies were facilitated by the development of a double-fluorescent assay that 
enabled  independent  recognition  of membrane-  and  intracellular-associated  cell 
components in isolated marrow megakaryocytes. Using the fluorescent double-assay 
systems,  it  was  demonstrated  that  factor VIII:AGN,  platelet  gtycoproteins Ib,  IIb, 
and  IIIa, as well as fibronectin, were expressed both on the membrane and  in  the 
intracellular compartment of megakaryocytes. 
Three major platelet  glycoproteins, Ib,  IIb, and  IIIa, were detected in >90%  of 
isolated  megakaryocytes.  These  glycoproteins were  detected on  the  membrane  of 
living cells as well as in the intracellular compartment of megakaryocytes after fixing 
cells with methanol, indicating that certain antigenic determinants of the glycopro- 
teins r.ot readily exposed to the outer surface of the cell membrane become accessible 
to  the  antibody preparations  after fixing the  cells.  This  is  in  agreement  with  the E.  RABELLINO, R.  LEVENE, L. LEUNG, AND R.  NA(3HMAN  97 
transmembrane location of these glycoproteins in the platelet membrane (31).  The 
intracellular compartment may also reflect storage sites of newly synthesized mem- 
brane constituents. In addition, platelet glycoproteins IIb and IIIa were detected as 
independent molecular entities in megakaryocytes since detection of either glycopro- 
tein was not inhibited when cells were incubated simultaneously or alternately with 
both  reagents.  This  observation  is  in  agreement  with  recent  studies  showing  the 
separate structural identity of these membrane glycoproteins (20, 32). 
Factor VIII:AGN  has  been  demonstrated  in  platelets,  endothelial  cells,  and  in 
megakaryocytes (33-36). Two pools of factor VIII:AGN, one associated with intra- 
cellular organelles and the other with the cell membrane, have been detected in >90% 
of isolated human marrow megakaryocytes. In a previous communication, we reported 
a similar finding, but only 10% of the isolated megakaryocytes contained intracellular 
factor VIII:AGN (1). The differences encountered may be a result of the cell fixative 
used; methanol rather than acetone was used in the current experiments. Synthesis of 
factor VIII:AGN has  been demonstrated in guinea pig megakaryocytes (8).  Mega- 
karyocytes appear  to  be  the  source  of intracellular  granule  factor  VIII:AGN  in 
platelets (37). More controversial is the role of membrane-associated factor VIII:AGN. 
In platelets, it has been suggested that membrane factor VIII:AGN is involved in the 
process of platelet adhesion  (37).  The significance and fate of membrane-associated 
factor VIII:AGN in megakaryocytes remains to be determined. 
FcR  and  Ia  antigen  have  been  recognized as  differentiation markers  of the  B- 
lymphoid monocytic, myeloid, and erythroid series (38-41). Parallel studies of mega- 
karyocytes and small, low density marrow cells disclosed that FcR were found on all 
mature megakaryocytes and small marrow cells bearing platelet markers, whereas Ia 
antigen was only detected on a proportion of mature megakaryocytes, but not on any 
of the megakaryocytic precursors. The fact that a  proportion of mature megakaryo- 
cytes and not precursor megakaryocytes bore Ia antigens indicated that the expression 
of this marker was restricted to a subclass of megakaryocytes. Expression of Ia antigen 
may take place at an intermediate stage of megakaryocyte differentiation as described 
in the myeloid series (41). Alternatively, it may reflect the development of a separate 
megakaryocyte lineage with restricted differentiation and functional properties. 
We conclude that  at least two major differentiation compartments can be recog- 
nized  in  human  megakaryocytopoiesis: one  that  includes  mature  megakaryocytes 
recognizable by their morphology, and the other that comprises a population of small 
low  density  lymphoid-like  marrow  cells  that  can  only  be  identified  by  virtue  of 
platelet protein markers. The factors regulating the population dynamics of these two 
compartments in health and disease remain subjects for future studies. 
Summary 
Analysis  of various  platelet  proteins by immunofluorescence demonstrated  that 
platelet glycoproteins Ib, IIb, and IIIa, as well as plasma factor VIII antigen (factor 
VIII:AGN),  platelet  factor 4,  and  flbronectin are  present  in  the  vast  majority of 
morphologically recognizable megakaryocytes. In addition, a small number of lymph- 
oid-like  mononuclear  marrow  cells,  representing  -1.4-2.9/104  marrow  cells,  was 
found to express the same platelet proteins. This population of early marrow mega- 
karyocytes is analogous to small acetylcholinesterase-positive rat and mouse marrow 
cells. Fc receptors for IgG were expressed in all megakaryocytes and megakaryocyte 98  PLATELET PROTEIN MARKERS IN MEGAKARYOCYTE  DIFFERENTIATION 
precursors,  whereas  the  Ia  antigen  was  detected  only  on  a  proportion  of mature 
megakaryocytes and not on any early or precursor megakaryocytes. Platelet glycopro- 
teins  Ib,  IIb,  and  IIIa,  as  well  as  factor  VIII:AGN,  and  platelet  factor  4  were 
established  as distinct  markers  for marrow  megakaryocytes and  may be helpful  for 
identifying  megakaryocytic cells  as well  as  for monitoring events of megakaryocyte 
differentiation. 
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